OTUB1 alleviates NASH through inhibition of the TRAF6‐ASK1 signaling pathways-Reference-Cited by-同舟云学术

OTUB1 alleviates NASH through inhibition of the TRAF6‐ASK1 signaling pathways

Published:2021-12-07 Issue: Volume: Page:
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Zhang Jie‐Lei¹,Du Bin‐Bin²,Zhang Dian‐Hong²,Li Huan²,Kong Ling‐Yao²,Fan Guang‐Jian³,Li Ya‐Peng²,Li Peng‐Cheng²,Liang Cui²,Wang Zheng²,Yang Lu‐Lu²,Hao Zheng‐Yang²,Wu Lei‐Ming²,Huang Zhen²,Dong Jian‐Zeng²,Zhang Jin‐Ying²,Yao Rui²,Wang Shou‐Jun¹,Zhang Yan‐Zhou²

Affiliation:

1. Department of Endocrinology the First Affiliated Hospital of Zhengzhou UniversityZhengzhou University Zhengzhou China

2. Cardiovascular Hospitalthe First Affiliated Hospital of Zhengzhou UniversityZhengzhou University Zhengzhou China

3. Precision Research Center for Refractory Diseases, Institute for Clinical Research Shanghai General HospitalShanghai Jiao Tong University School of Medicine Shanghai China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.32179

Reference47 articles.

1. Mechanisms of NAFLD development and therapeutic strategies

2. Non-alcoholic fatty liver disease (NAFLD) – pathogenesis, classification, and effect on drug metabolizing enzymes and transporters

3. Hepatic IRF2BP2 Mitigates Nonalcoholic Fatty Liver Disease by Directly Repressing the Transcription of ATF3